Rajiv Indravadan Modi

Rajiv Indravadan Modi is currently the Chairman & Managing Director at Cadila Pharmaceuticals Ltd.
He is also the Chairman-Governors Board at the Indian Institute of Technology Guwahati.
In addition, he serves as a Director at EQL Pharma AB, Apollo Hospitals International Ltd., Karnavati Engineering Ltd., Casil Health Products Ltd., Casil Industries Ltd., IRM Ltd., Green Channel Logi-Solutions Ltd., Cadila Laboratories Pvt Ltd., Stemcyte India Therapeutics Pvt.
Ltd., CPL Biologicals Pvt Ltd., CPL Agro Products Pvt Ltd., CPL Holdings Pvt Ltd., CPL Infrastructure Pvt Ltd., IRM Enterprises Pvt Ltd., Casil Bg Medical Devices Pvt Ltd., Inverika Bioresearch Pvt Ltd., Energy Hunter Resources, Inc., IRM Energy Ltd.
(as a Non-Executive Director), and is a Member of the New York Academy of Sciences, The Genetics Society of America, and the American Society for Microbiology.
Dr. Modi's former positions include Council Chairman at the Confederation of Indian Industry (Gujarat), Director at Novavax, Inc. (from 2009 to 2022), Independent Non-Executive Director at Gujarat Alkalies & Chemicals Ltd., Director at Satellite Overseas (Holdings) Ltd., and Director at Targeted Microwave Solutions, Inc. (from 2015 to 2017).
Regarding education, Dr. Modi holds a doctorate degree from the University of Michigan, a graduate degree from University College London, and an undergraduate degree from the Indian Institute of Technology Bombay.